Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (Mini-hyper-CVD) with or without Blinatumomab Is Highly Effective in Patients (pts) with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Koji Sasaki, Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short, Partow Kebriaei, Xuelin Huang, Michael E. Rytting, Nitin Jain, Marina Y Konopleva, Guillermo Garcia-Manero, Richard E. Champlin, Tapan M. Kadia, Jorge E. Cortes, Zeev E. Estrov, Koichi Takahashi, Christopher Loiselle, Corabelle Encarnacion, Meagan Rostykus, Rita Khouri, Patrice Nasnas, Jovitta Jacob, Monica Kwari, Rebecca Garris, Elias Jabbour
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2985453047